SONN — Sonnet Biotherapeutics Holdings Balance Sheet
0.000.00%
Last trade - 00:00- $24.78m
- $24.46m
- $0.02m
Annual balance sheet for Sonnet Biotherapeutics Holdings, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 7.35 | 27.6 | 3.05 | 2.27 | 0.149 |
| Net Total Receivables | — | — | — | 0.787 | 0.762 |
| Prepaid Expenses | |||||
| Total Current Assets | 7.64 | 28.8 | 5.41 | 4.74 | 2.12 |
| Net Property, Plant And Equipment | 0.274 | 0.182 | 0.303 | 0.227 | 0.144 |
| Other Long Term Assets | |||||
| Total Assets | 7.99 | 29 | 5.83 | 5.43 | 2.77 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.72 | 6.7 | 8.16 | 5.52 | 3.21 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.97 | 6.73 | 8.37 | 5.66 | 3.26 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 3.02 | 22.3 | -2.54 | -0.226 | -0.486 |
| Total Liabilities & Shareholders' Equity | 7.99 | 29 | 5.83 | 5.43 | 2.77 |
| Total Common Shares Outstanding |